Reviewing Prestige Consumer Healthcare Inc. (PBH)’s and Apollo Endosurgery Inc. (NASDAQ:APEN)’s results

Reviewing Prestige Consumer Healthcare Inc. (PBH)’s and Apollo Endosurgery Inc. (NASDAQ:APEN)’s results

December 8, 2019 Off By administrator

Prestige Consumer Healthcare Inc. (NYSE:PBH) and Apollo Endosurgery Inc. (NASDAQ:APEN) compete against each other in the Medical Appliances & Equipment sector. We will compare them and contrast their analyst recommendations, profitability, risk, institutional ownership, dividends, earnings and valuation.

Valuation and Earnings

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Prestige Consumer Healthcare Inc. 37 2.25 50.08M -0.71 0.00
Apollo Endosurgery Inc. 3 0.00 9.52M -1.81 0.00

Demonstrates Prestige Consumer Healthcare Inc. and Apollo Endosurgery Inc. earnings per share, gross revenue and valuation.

Profitability

Table 2 represents Prestige Consumer Healthcare Inc. (NYSE:PBH) and Apollo Endosurgery Inc. (NASDAQ:APEN)’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Prestige Consumer Healthcare Inc. 135,387,942.69% -3.1% -1%
Apollo Endosurgery Inc. 329,959,794.81% -117.1% -49.9%

Volatility & Risk

Prestige Consumer Healthcare Inc. is 9.00% less volatile than S&P 500 because the stock has a beta of 0.91. From a competition point of view, Apollo Endosurgery Inc. has a 0.75 beta which is 25.00% less volatile compared to S&P 500.

Liquidity

The current Quick Ratio of Prestige Consumer Healthcare Inc. is 1.4 while its Current Ratio is 2.4. Meanwhile, Apollo Endosurgery Inc. has a Current Ratio of 2.8 while its Quick Ratio is 2.2. Apollo Endosurgery Inc. is better positioned to pay off its short-term and long-term debts than Prestige Consumer Healthcare Inc.

Analyst Ratings

In next table is given Prestige Consumer Healthcare Inc. and Apollo Endosurgery Inc.’s ratings and recommendations.

Sell Ratings Hold Ratings Buy Ratings Rating Score
Prestige Consumer Healthcare Inc. 0 1 0 2.00
Apollo Endosurgery Inc. 0 0 0 0.00

The consensus price target of Prestige Consumer Healthcare Inc. is $32, with potential downside of -16.27%.

Insider and Institutional Ownership

Roughly 44.05% of Prestige Consumer Healthcare Inc. shares are owned by institutional investors while 65.8% of Apollo Endosurgery Inc. are owned by institutional investors. Insiders owned roughly 0.5% of Prestige Consumer Healthcare Inc.’s shares. Competitively, 13.9% are Apollo Endosurgery Inc.’s share owned by insiders.

Performance

In this table we show the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
Prestige Consumer Healthcare Inc. 3.84% 6.4% 19.19% 25.45% -3.73% 12.05%
Apollo Endosurgery Inc. -2.15% -12.5% -25.82% -23.1% -66.95% -20.87%

For the past year Prestige Consumer Healthcare Inc. has 12.05% stronger performance while Apollo Endosurgery Inc. has -20.87% weaker performance.

Summary

Prestige Consumer Healthcare Inc. beats Apollo Endosurgery Inc. on 8 of the 11 factors.

Prestige Brands Holdings, Inc.,…

(Excerpt) To read the full article , click here
Image credit: source